Fay Judy Strohschein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fay Judy Strohschein has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Lorelei Newton
University of Victoria
6 shared publications - Margaret I. Fitch
Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON M5T 1P8, Canada
6 shared publications - Martine Puts
Lawrence Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
5 shared publications - Carmen G. Loiselle
Gerald Bronfman Department of Oncology, and Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2M7, Canada
4 shared publications Gina Lockwood
Biostatistician Consultant, Toronto, Canada
4 shared publicationsIrene Nicoll
Healthcare Consultant, Toronto, Canada
4 shared publications
Latest Publications
- Open Access
- 2 March 2026
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 17 (3) , 102906
Nursing practice in cancer treatment decision making among older adults: A scoping review on behalf of the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists Interest Group
- 2 March 2026
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 17 (3) , 102906
Open AccessNursing practice in cancer treatment decision making among older adults: A scoping review on behalf of the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists Interest Group
- Open Access
- 28 February 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 142
Exploring the Impact of Gender and Income on Concerns Reported by Cancer Survivors Aged ≥85 Years in Canada: A Secondary Analysis of the Canadian Transitions Survey
This study describes concerns, positive experiences and suggestions for improvement in survivorship care from the perspectives of cancer survivors aged ≥85 years based on gender and income levels. A national Canadian survey was conducted in 2016 focusing on cancer survivors’ needs and experiences with follow-up care after treatment. This paper reports a secondary analysis drawn from the survey data reported qualitatively. In total, 581 respondents aged ≥85 years responded, of which 399 confirmed gender and annual household income. Within this group, 201 were male, and 198 were female. Two-thirds of the males (n = 134 males, 66.7%) and 80.8% of the females (n = 160) reported annual household income under $50K (CAD). Limited differences were noted between survivors’ responses according to sex and/or income levels. Concerns focused on physical challenges and body changes. Positive comments reflected appreciation of the care provided by attentive healthcare professionals. Suggestions for improvement addressed the need for improved person-centred care and availability of services for older adults. The survivors faced a range of physical, emotional and practical challenges following cancer treatment. The study highlights the importance of considering how living alone or with others, community connection, and the burden of co-morbidities compounding physical challenges after cancer intersect to create unique situations for this age group.
- 28 February 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 142
Open AccessExploring the Impact of Gender and Income on Concerns Reported by Cancer Survivors Aged ≥85 Years in Canada: A Secondary Analysis of the Canadian Transitions Survey
This study describes concerns, positive experiences and suggestions for improvement in survivorship care from the perspectives of cancer survivors aged ≥85 years based on gender and income levels. A national Canadian survey was conducted in 2016 focusing on cancer survivors’ needs and experiences with follow-up care after treatment. This paper reports a secondary analysis drawn from the survey data reported qualitatively. In total, 581 respondents aged ≥85 years responded, of which 399 confirmed gender and annual household income. Within this group, 201 were male, and 198 were female. Two-thirds of the males (n = 134 males, 66.7%) and 80.8% of the females (n = 160) reported annual household income under $50K (CAD). Limited differences were noted between survivors’ responses according to sex and/or income levels. Concerns focused on physical challenges and body changes. Positive comments reflected appreciation of the care provided by attentive healthcare professionals. Suggestions for improvement addressed the need for improved person-centred care and availability of services for older adults. The survivors faced a range of physical, emotional and practical challenges following cancer treatment. The study highlights the importance of considering how living alone or with others, community connection, and the burden of co-morbidities compounding physical challenges after cancer intersect to create unique situations for this age group.
- 1 May 2025
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 16 (4) , 102238
Strengthening interprofessional and interdisciplinary collaboration in geriatric oncology initiatives: An adapted World Café at the 2024 International Society of Geriatric Oncology (SIOG) Annual Conference, a joint initiative of the SIOG Nursing, Allied Health, and Scientists Interest Group and the Canadian Association of Nurses in Oncology (CANO) Oncology and Aging Special Interest Group
- 1 May 2025
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 16 (4) , 102238
Strengthening interprofessional and interdisciplinary collaboration in geriatric oncology initiatives: An adapted World Café at the 2024 International Society of Geriatric Oncology (SIOG) Annual Conference, a joint initiative of the SIOG Nursing, Allied Health, and Scientists Interest Group and the Canadian Association of Nurses in Oncology (CANO) Oncology and Aging Special Interest Group
- Open Access
- 13 March 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (3) , 1483-1503
A Retrospective Age Analysis of the Ambulatory Oncology Patient Satisfaction Survey: Differences in Satisfaction across Dimensions of Person-Centred Care and Unmet Needs among Older Adults Receiving Cancer Treatment
Over half of all new cancer cases in Alberta are diagnosed among people aged 65+ years, a group that encompasses vast variation. Patient-reported experience measures are routinely collected within Cancer Care Alberta; however, the specific consideration of the needs and concerns of older Albertans with cancer is lacking. In 2021, 2204 adults who had received treatment at a cancer centre in Alberta completed the Ambulatory Oncology Patient Satisfaction Survey (AOPSS). In this study, we explored the age differences in satisfaction across six dimensions of person-centred care and in the proportions of unmet needs across eight types of issues, with specific attention to older adults. Using three age groups (18–39, 40–64, 65+), only the physical comfort dimension showed significantly lower satisfaction among those aged 65+ years. Using five age groups (18–39, 40–64, 65–74, 75–84, 85+), significantly lower levels of satisfaction were found related to ‘physical comfort’ for those aged 65–74 and 75–84, ‘coordination and continuity of care’ for those aged 75–84 and 85+, and ‘information, communication, and education’ for those aged 85+. Therefore, grouping together all older adults aged 65+ years obscured lower levels of satisfaction with some dimensions of person-centred care among those aged 75–84 and 85+ years. Unmet needs generally increased with age for all types of issues, with significant differences across age groups for emotional, financial, social/family, and sexual health issues. The lower levels of satisfaction and higher proportions of unmet needs call for tailored interventions to promote optimal care experiences and outcomes among older adults receiving cancer care in Alberta and their families.
- 13 March 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (3) , 1483-1503
Open AccessA Retrospective Age Analysis of the Ambulatory Oncology Patient Satisfaction Survey: Differences in Satisfaction across Dimensions of Person-Centred Care and Unmet Needs among Older Adults Receiving Cancer Treatment
Over half of all new cancer cases in Alberta are diagnosed among people aged 65+ years, a group that encompasses vast variation. Patient-reported experience measures are routinely collected within Cancer Care Alberta; however, the specific consideration of the needs and concerns of older Albertans with cancer is lacking. In 2021, 2204 adults who had received treatment at a cancer centre in Alberta completed the Ambulatory Oncology Patient Satisfaction Survey (AOPSS). In this study, we explored the age differences in satisfaction across six dimensions of person-centred care and in the proportions of unmet needs across eight types of issues, with specific attention to older adults. Using three age groups (18–39, 40–64, 65+), only the physical comfort dimension showed significantly lower satisfaction among those aged 65+ years. Using five age groups (18–39, 40–64, 65–74, 75–84, 85+), significantly lower levels of satisfaction were found related to ‘physical comfort’ for those aged 65–74 and 75–84, ‘coordination and continuity of care’ for those aged 75–84 and 85+, and ‘information, communication, and education’ for those aged 85+. Therefore, grouping together all older adults aged 65+ years obscured lower levels of satisfaction with some dimensions of person-centred care among those aged 75–84 and 85+ years. Unmet needs generally increased with age for all types of issues, with significant differences across age groups for emotional, financial, social/family, and sexual health issues. The lower levels of satisfaction and higher proportions of unmet needs call for tailored interventions to promote optimal care experiences and outcomes among older adults receiving cancer care in Alberta and their families.
- Open Access
- 1 January 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (1) , 59-69
Cost-Utility Analysis of Geriatric Assessment and Management in Older Adults With Cancer: Economic Evaluation Within 5C Trial
PURPOSE: Geriatric assessment (GA) is a guideline-recommended approach to optimize cancer management in older adults. We conducted a cost-utility analysis alongside the 5C randomized controlled trial to compare GA and management (GAM) plus usual care (UC) against UC alone in older adults with cancer. METHODS: The economic evaluation, conducted from societal and health care payer perspectives, used a 12-month time horizon. The Canadian 5C study randomly assigned patients to receive GAM or UC. Quality-adjusted life-years (QALYs) were measured using the EuroQol five dimension-5L questionnaire and health care utilization using cost diaries and chart reviews. We evaluated the incremental net monetary benefit (INMB) for the full sample and preselected subgroups. RESULTS: A total of 350 patients were included, of whom 173 received GAM and 177 UC. At 12 months, the average QALYs per patient were 0.728 and 0.751 for GAM and UC, respectively (ΔQALY, −0.023 [95% CI, −0.076 to 0.028]). Considering a societal perspective, the total average costs (in 2021 Canadian dollars) per patient were $46,739 and $45,177 for GAM and UC, respectively (ΔCost, $1,563 [95% CI, −$6,583 to $10,403]). At a cost-effectiveness threshold of $50,000/QALY, GAM was not cost-effective compared with UC (INMB, −$2,713 [95% CI, −$11,767 to $5,801]). The INMB was positive ($2,984 [95% CI, −$7,050 to $14,179]; probability of being cost-effective, 72%) for patients treated with curative intent, but remained negative for patients treated with palliative intent (INMB, −$9,909 [95% CI, −$24,436 to $4,153]). Findings were similar considering a health care payer perspective. CONCLUSION: To our knowledge, this is the first cost-utility analysis of GAM in cancer. GAM was cost-effective for patients with cancer treated with curative but not with palliative intent. The study provides further considerations for future adoption of GAM in practice.
- 1 January 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (1) , 59-69
Open AccessCost-Utility Analysis of Geriatric Assessment and Management in Older Adults With Cancer: Economic Evaluation Within 5C Trial
PURPOSE: Geriatric assessment (GA) is a guideline-recommended approach to optimize cancer management in older adults. We conducted a cost-utility analysis alongside the 5C randomized controlled trial to compare GA and management (GAM) plus usual care (UC) against UC alone in older adults with cancer. METHODS: The economic evaluation, conducted from societal and health care payer perspectives, used a 12-month time horizon. The Canadian 5C study randomly assigned patients to receive GAM or UC. Quality-adjusted life-years (QALYs) were measured using the EuroQol five dimension-5L questionnaire and health care utilization using cost diaries and chart reviews. We evaluated the incremental net monetary benefit (INMB) for the full sample and preselected subgroups. RESULTS: A total of 350 patients were included, of whom 173 received GAM and 177 UC. At 12 months, the average QALYs per patient were 0.728 and 0.751 for GAM and UC, respectively (ΔQALY, −0.023 [95% CI, −0.076 to 0.028]). Considering a societal perspective, the total average costs (in 2021 Canadian dollars) per patient were $46,739 and $45,177 for GAM and UC, respectively (ΔCost, $1,563 [95% CI, −$6,583 to $10,403]). At a cost-effectiveness threshold of $50,000/QALY, GAM was not cost-effective compared with UC (INMB, −$2,713 [95% CI, −$11,767 to $5,801]). The INMB was positive ($2,984 [95% CI, −$7,050 to $14,179]; probability of being cost-effective, 72%) for patients treated with curative intent, but remained negative for patients treated with palliative intent (INMB, −$9,909 [95% CI, −$24,436 to $4,153]). Findings were similar considering a health care payer perspective. CONCLUSION: To our knowledge, this is the first cost-utility analysis of GAM in cancer. GAM was cost-effective for patients with cancer treated with curative but not with palliative intent. The study provides further considerations for future adoption of GAM in practice.
- Open Access
- 29 March 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-11
Relationship between income and concerns about physical changes and help-seeking by older adult cancer survivors: a secondary analysis
Objective: Globally, the number of older adults surviving cancer is anticipated to grow rapidly over the next decades. Cancer and its treatment can leave survivors with a myriad of challenges including physical changes which impact independence and quality of life. This project explored the relationship of income level with concerns and help-seeking for physical changes following treatment in older Canadian survivors of cancer. Methods: A Canada-wide survey of community-dwelling survivors of cancer explored their experiences with survivorship care one to three years following completion of treatment. A secondary trend analysis examined the relationship of income with older adults’ level of concern and help-seeking experiences regarding physical consequences they attributed to their cancer treatment. Results: In total, 7,975 people aged 65 years and older who survived cancer responded to the survey, of whom 5,891 (73.9%) indicated annual household income. Prostate (31.3%), colorectal (22.7%) and breast (21.8%) cancer accounted for the majority of respondents. Of those who reported household income data, over 90% wrote about the impact of physical changes following treatment, their concerns about the changes, and whether they sought help for their concerns. The most frequently identified physical challenge was fatigue (63.7%). Older survivors with low annual household incomes of less than $CA25,000 reported the highest levels of concern about multiple physical symptoms. 25% or more of the survey respondents across all income levels reported difficulty finding assistance for their concerns about the physical challenges, especially in their local communities. Conclusion: Older survivors of cancer can experience a range of physical changes, amenable to intervention by physical therapy, yet experience challenges obtaining relevant help. Those with low income are more severely affected, even within a universal healthcare system. Financial assessment and tailored follow-up are recommended.
- 29 March 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-11
Open AccessRelationship between income and concerns about physical changes and help-seeking by older adult cancer survivors: a secondary analysis
Objective: Globally, the number of older adults surviving cancer is anticipated to grow rapidly over the next decades. Cancer and its treatment can leave survivors with a myriad of challenges including physical changes which impact independence and quality of life. This project explored the relationship of income level with concerns and help-seeking for physical changes following treatment in older Canadian survivors of cancer. Methods: A Canada-wide survey of community-dwelling survivors of cancer explored their experiences with survivorship care one to three years following completion of treatment. A secondary trend analysis examined the relationship of income with older adults’ level of concern and help-seeking experiences regarding physical consequences they attributed to their cancer treatment. Results: In total, 7,975 people aged 65 years and older who survived cancer responded to the survey, of whom 5,891 (73.9%) indicated annual household income. Prostate (31.3%), colorectal (22.7%) and breast (21.8%) cancer accounted for the majority of respondents. Of those who reported household income data, over 90% wrote about the impact of physical changes following treatment, their concerns about the changes, and whether they sought help for their concerns. The most frequently identified physical challenge was fatigue (63.7%). Older survivors with low annual household incomes of less than $CA25,000 reported the highest levels of concern about multiple physical symptoms. 25% or more of the survey respondents across all income levels reported difficulty finding assistance for their concerns about the physical challenges, especially in their local communities. Conclusion: Older survivors of cancer can experience a range of physical changes, amenable to intervention by physical therapy, yet experience challenges obtaining relevant help. Those with low income are more severely affected, even within a universal healthcare system. Financial assessment and tailored follow-up are recommended.
- Open Access
- 1 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (4) , 847-858
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial
PURPOSE: American Society of Clinical Oncology recommends that older adults with cancer being considered for chemotherapy receive geriatric assessment (GA) and management (GAM), but few randomized controlled trials have examined its impact on quality of life (QOL). PATIENTS AND METHODS: The 5C study was a two-group parallel 1:1 single-blind multicenter randomized controlled trial of GAM for 6 months versus usual oncologic care. Eligible patients were age 70+ years, diagnosed with a solid tumor, lymphoma, or myeloma, referred for first-/second-line chemotherapy or immunotherapy or targeted therapy, and had an Eastern Cooperative Oncology Group performance status of 0-2. The primary outcome QOL was measured with the global health scale of the European Organisation for the Research and Treatment of Cancer QOL questionnaire and analyzed with a pattern mixture model using an intent-to-treat approach (at 6 and 12 months). Secondary outcomes included functional status, grade 3-5 treatment toxicity; health care use; satisfaction; cancer treatment plan modification; and overall survival. RESULTS: From March 2018 to March 2020, 350 participants were enrolled. Mean age was 76 years and 40.3% were female. Fifty-four percent started treatment with palliative intent. Eighty-one (23.1%) patients died. GAM did not improve QOL (global QOL of 4.4 points [95% CI, 0.9 to 8.0] favoring the control arm). There was also no difference in survival, change in treatment plan, unplanned hospitalization/emergency department visits, and treatment toxicity between groups. CONCLUSION: GAM did not improve QOL. Most intervention group participants received GA on or after treatment initiation per patient request. Considering recent completed trials, GA may have benefit if completed before treatment selection. The COVID-19 pandemic may have affected our QOL outcome and intervention delivery for some participants.
- 1 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (4) , 847-858
Open AccessImpact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial
PURPOSE: American Society of Clinical Oncology recommends that older adults with cancer being considered for chemotherapy receive geriatric assessment (GA) and management (GAM), but few randomized controlled trials have examined its impact on quality of life (QOL). PATIENTS AND METHODS: The 5C study was a two-group parallel 1:1 single-blind multicenter randomized controlled trial of GAM for 6 months versus usual oncologic care. Eligible patients were age 70+ years, diagnosed with a solid tumor, lymphoma, or myeloma, referred for first-/second-line chemotherapy or immunotherapy or targeted therapy, and had an Eastern Cooperative Oncology Group performance status of 0-2. The primary outcome QOL was measured with the global health scale of the European Organisation for the Research and Treatment of Cancer QOL questionnaire and analyzed with a pattern mixture model using an intent-to-treat approach (at 6 and 12 months). Secondary outcomes included functional status, grade 3-5 treatment toxicity; health care use; satisfaction; cancer treatment plan modification; and overall survival. RESULTS: From March 2018 to March 2020, 350 participants were enrolled. Mean age was 76 years and 40.3% were female. Fifty-four percent started treatment with palliative intent. Eighty-one (23.1%) patients died. GAM did not improve QOL (global QOL of 4.4 points [95% CI, 0.9 to 8.0] favoring the control arm). There was also no difference in survival, change in treatment plan, unplanned hospitalization/emergency department visits, and treatment toxicity between groups. CONCLUSION: GAM did not improve QOL. Most intervention group participants received GA on or after treatment initiation per patient request. Considering recent completed trials, GA may have benefit if completed before treatment selection. The COVID-19 pandemic may have affected our QOL outcome and intervention delivery for some participants.
- 1 April 2022
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 13 (3) , 346-355
International trends in cancer incidence in middle-aged and older adults in 44 countries
- 1 April 2022
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 13 (3) , 346-355
International trends in cancer incidence in middle-aged and older adults in 44 countries
- 1 April 2022
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 13 (3) , 337-345
Exploring the relationships between income and emotional/practical concerns and help-seeking by older adult cancer survivors: A secondary analysis
- 1 April 2022
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 13 (3) , 337-345
Exploring the relationships between income and emotional/practical concerns and help-seeking by older adult cancer survivors: A secondary analysis